Sustainability | January 24, 2026
Lupin receives highest ESG rating from CDP for climate change and water security
Lupin’s double ‘A’ rating in Climate and Water exemplifies its steadfast commitment to sustainability
Lupin’s double ‘A’ rating in Climate and Water exemplifies its steadfast commitment to sustainability
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
EMA recommended 30 veterinary medicines for marketing authorisation in 2025
This marks the second indication for which gumokimab has gained NDA review acceptance
Tatva Chintan Pharma Chem has reported total income of Rs. 133.06 crore during the period ended December 31, 2025
The RMAT designation accelerates the development of regenerative medicine therapies for serious or life-threatening diseases
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
In Q3 FY26, Senores posted consolidated revenue of Rs. 175 crore, up 64% year-on-year.
Sofetabart mipitecan is a novel folate receptor alpha (FR?) antibody-drug conjugate (ADC) leveraging proprietary linker technology and an exatecan payload to target tumor cells
Stevens succeeds Milton Boyer, who has stepped down as CEO but will remain closely involved with the business as an independent member of Kindeva’s Board of Directors
Subscribe To Our Newsletter & Stay Updated
